Stock Research for EBS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

EBS Stock Chart & Research Data

The EBS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EBS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EBS Due diligence Resources & Stock Charts

The EBS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EBS Detailed Price Forecast - CNN Money CNN View EBS Detailed Summary - Google Finance
Yahoo View EBS Detailed Summary - Yahoo! Finance Zacks View EBS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View EBS Trends & Analysis - Trade-Ideas Barrons View EBS Major Holders - Barrons
NASDAQ View EBS Call Transcripts - NASDAQ Seeking View EBS Breaking News & Analysis - Seeking Alpha
Spotlight View EBS Annual Report - CompanySpotlight.com OTC Report View EBS OTC Short Report - OTCShortReport.com
TradeKing View EBS Fundamentals - TradeKing Charts View EBS SEC Filings - Bar Chart
WSJ View Historical Prices for EBS - The WSJ Morningstar View Performance/Total Return for EBS - Morningstar
MarketWatch View the Analyst Estimates for EBS - MarketWatch CNBC View the Earnings History for EBS - CNBC
StockMarketWatch View the EBS Earnings - StockMarketWatch MacroAxis View EBS Buy or Sell Recommendations - MacroAxis
Bullish View the EBS Bullish Patterns - American Bulls Short Pains View EBS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View EBS Stock Mentions - StockTwits PennyStocks View EBS Stock Mentions - PennyStockTweets
Twitter View EBS Stock Mentions - Twitter Invest Hub View EBS Investment Forum News - Investor Hub
Yahoo View EBS Stock Mentions - Yahoo! Message Board Seeking Alpha View EBS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for EBS - SECform4.com Insider Cow View Insider Transactions for EBS - Insider Cow
CNBC View EBS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EBS - OTC Markets
Yahoo View Insider Transactions for EBS - Yahoo! Finance NASDAQ View Institutional Holdings for EBS - NASDAQ


Stock Charts

FinViz View EBS Stock Insight & Charts - FinViz.com StockCharts View EBS Investment Charts - StockCharts.com
BarChart View EBS Stock Overview & Charts - BarChart Trading View View EBS User Generated Charts - Trading View




Latest Financial News for EBS


Emergent Biosolutions (EBS) Down 24.2% Since Last Earnings Report: Can It Rebound?
Posted on Saturday March 23, 2019

Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.


Emergent Begins Phase III Study on Anthrax Vaccine AV7909
Posted on Wednesday March 20, 2019

Emergent (EBS) kicks off a late-stage study on its investigational anthrax vaccine AV7909.


Emergent BioSolutions Initiates Phase 3 Clinical Study to Evaluate AV7909 for Post-Exposure Prophylaxis of Anthrax
Posted on Tuesday March 19, 2019

Emergent BioSolutions Inc. (EBS) today announced the initiation of a Phase 3 trial to evaluate the lot consistency, immunogenicity, and safety of AV7909 (anthrax vaccine adsorbed with CPG 7909 adjuvant) following a two-dose schedule administered intramuscularly in healthy adults. “Emergent is pleased with the advancement of the AV7909 development program,” said Abbey Jenkins, senior vice president and vaccines and anti-infectives business unit head at Emergent BioSolutions. AV7909 is designed to elicit a faster immune response than the currently available anthrax vaccine.


Life Sciences Pa. reveals awards for its top CEO, top products and deal of the year
Posted on Thursday March 14, 2019

Pennsylvania's life sciences industry honored its own Wednesday night as awards where handed out at Life Sciences Pennsylvania's annual dinner. The event at the Pennsylvania Convention Center drew a record crowd of more than 1,300 people. The awards include two named in honor of biotech pioneer's Hubert J. P. Schoemaker, the co-founder of Centocor, and Frank Baldino Jr., the co-founder of Cephalon.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.